Large-scale testing of the vaccine, developed by Moscow's Gamaleya institute, is due to start in Russia this week.
The vaccine, called “Sputnik V” in homage to the world’s first satellite launched by the Soviet Union, has already received approval from domestic regulators, leading President Vladimir Putin and other officials to name Russia the first country to license a COVID-19 vaccine.